Next Generation Research Fellowships

Founded in 2023, our Next Generation Cancer Research Fellowships mark a new era of cancer research at Cancer Council Queensland.

Replacing the ACCR grants scheme, these fellowships fund early career cancer researchers who are on the front-line of clinical innovations in cancer detection and treatment.

Cancer Council Queensland is pleased to offer a funding opportunity for early career researchers in Queensland: “Cancer Council Queensland Next Generation Cancer Research Fellowships”.

Cancer Council Queensland is partnering with the National Health and Medical Research Council (NHMRC) on the NHMRC Investigator Grant Scheme.

Research breakdown
Your donation makes a real impact

Contributions go towards world-class research, prevention programs and support service.

Eligibility and application process

Applications will be via the NHMRC Investigator Grant application process. Details can be found on the GrantConnect and NHMRC websites.

Cancer Council Queensland will consider applicants for Emerging Leadership Level 1 (EL1) fellowships whose research proposal is focused on cancer.

Applicants for a Cancer Council Queensland Next Generation Cancer Research Fellowship must tick the ‘Cancer Council Queensland’ box in the Partner Organisation section of the NHMRC Investigator Grant application form submit their application through an Administering Institution in Queensland ensure at least 75% of the planned research is conducted at the Administering Institution or Participating Institutions in Queensland, this percentage to be calculated from the Research Effort percentages listed by applicants in Section 5.3 of the application.

Cancer Council Queensland will consider applicants who meet the above criteria and are considered fundable but are unsuccessful in obtaining NHMRC funding.

Awarding

Up to four fellowships may be awarded per grant round.

Each fellowship will provide $150,000 per year for 5 years (comprising $50,000 for research costs and $100,000 towards salary).

A Funding Agreement outlining the terms and conditions of the fellowship will be established between Cancer Council Queensland and the recipient’s Administering Institution.

Requirements of fellowship

Recipients of the Cancer Council Queensland Next Generation Cancer Research Fellowships will be required to:

  1. participate in the annual research awards function
  2. assist in identification of publicity opportunities and be proactive in media promotion of newsworthy research outcomes as a result of Cancer Council Queensland’s funding and support
  3. acknowledge Cancer Council Queensland in any publications or media publicity relating to the supported research
  4. contribute to the fundraising activities of Cancer Council Queensland including meeting reasonable requests to attend and present at events and assist with research profiles for fundraising campaigns
  5. submit an annual progress report to Cancer Council Queensland.

Information for current Grant Recipients

Reporting requirements for recipients of Next Generation Cancer Research Fellowship Grants are outlined in the Funding Agreement. A list of relevant documentation is below:

Due dates for reporting

Progress and Financial reports – 28 February
Final reports – 30 April

How can I find out more information?

Enquiries about Cancer Council Queensland research funding opportunities should be directed to:

Manager, Research Operations
Telephone: (07) 3634 5393
Email: ResearchGrants@cancerqld.org.au

Meet the 2024 Next Generation Cancer Research Fellowship recipients

Dr Mostafa Kamal Masud

Dr. Masud, from The University of Queensland, is conducting research focused on developing a device which, using nanoengineered structures, aims to make it possible to detect early-stage ovarian cancer within 2 hours at a GP clinic.

Dr Jasmin Straube

Dr. Jasmin Straube from QIMR Berghofer is researching vulnerabilities in leukemic stem cells carrying poor prognostic mutations. Her work will play a critical role in improving outcomes for patients with myeloid blood cancer.

Dr Mathias Seviiri

Dr. Mathias Seviiri, also from QIMR Berghofer, is tackling the complex landscape of skin cancer. His research aims to unravel the complex relationships between genetics, treatment responses, and adverse events in patients undergoing treatment for melanoma and keratinocyte cancers.

Have other questions? Talk to us.

Our team is here to listen and support you.